The Legal 500: Pharmaceutical Advertising Comparative Guide 2022

The latest edition of the Legal 500: Pharmaceutical Advertising Comparative Guide is now online. The aim of this guide is to provide its readers with a pragmatic overview of the law and practice of pharmaceutical advertising law across a variety of jurisdictions.

Each chapter of this guide provides information about the current issues affecting pharmaceutical advertising in a particular country and addresses topics such as self-regulation, press releases, gifts, samples, grants or donations, anti-bribery rules, regulatory authorities and courts, as well as insight and opinion on the most common issues in their respective country.

The Q&A template for each chapter has been provided by Sally Shorthose.

Read our overview of Pharmaceutical Advertising laws and regulations applicable in:

Read the French chapter here
Read the German chapter here
Read the UK chapter here

Latest insights

More Insights
Curiosity line green background

China's Pharmaceutical Patent Term Extension Cases Reveal New Landscape for Innovative Drug Protection

Sep 17 2025

Read More
Curiosity line yellow background

Digital Duty of Care: What Phase 2 eSafety Codes Demand from Providers

Sep 16 2025

Read More
featured image

EU Revised Product Liability Directive 2024: Navigating the New Liability Framework for Non-EU Manufacturers

6 minutes Sep 04 2025

Read More